| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |